Columbia Care has entered into a merger agreement with Cresco Labs. Columbia shareholders will receive 0.5579 shares of Cresco for each of their securities and will own 35% of the combined company. The deal is scheduled to close in Q4 2022.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept